Several studies have suggested that combining the AURKA inhibitor alisertib with the FAO inhibitor etomoxir reduces glioblastoma cell growth, enhances glioblastoma cell death, and extends overall survival in orthotopic glioblastoma patient-derived xenograft models [18]. This evidence concerns the gene AURKA and glioblastoma.